Financials
Financial year 2025
Anesthesie-Intensieve Geneeskunde-Urgentiegeneeskunde-Pijncentrum ZOL from Genk, company number BE0691654144, closed financial year 2025 with a result of € -9,037 after tax. For that financial year Anesthesie-Intensieve Geneeskunde-Urgentiegeneeskunde-Pijncentrum ZOL recorded a gross margin of € -4,038 and equity of € 152,413. Compared with financial year 2024, the result moved from € 106,234 to € -9,037. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 8, 2026.
€ 152,413
▼ 5% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -9,037
▼ still € 106,234 profit in 2024
Profit after tax over the fiscal year.
€ 52,634
▼ 22% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € 143,613.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 487
▼ 85% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 49,920
▲ 5% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 43,779 | € 7,285 | € 154,448 | € -4,038 | ▼ € 158,486 |
| Profit after taxes | € 34,512 | € 614 | € 106,234 | € -9,037 | ▼ € 115,271 |
| Equity | € 54,402 | € 54,816 | € 161,050 | € 152,413 | ▼ 5% |
| Total debts | € 11,721 | € 5,538 | € 53,669 | € 53,507 | |
| Cash | € 16,905 | € 52,041 | € 67,424 | € 52,634 | ▼ 22% |
| Retained profit | € 45,802 | € 46,416 | € 152,650 | € 143,613 | ▼ 6% |
| Balance sheet total | € 66,123 | € 60,354 | € 214,719 | € 205,920 | ▼ 4% |
Key figures of Anesthesie-Intensieve Geneeskunde-Urgentiegeneeskunde-Pijncentrum ZOL, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Anesthesie-Intensieve Geneeskunde-Urgentiegeneeskunde-Pijncentrum ZOL?
What happened at Anesthesie-Intensieve Geneeskunde-Urgentiegeneeskunde-Pijncentrum ZOL in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Puram BV stepped down as director. NBB
- Coys Genk BV stepped down as director. NBB
- Gofi BV stepped down as director. NBB
- Dr. Tanghe Ignace BV stepped down as director. NBB
- Dr. Jente Grietens BV stepped down as director. NBB
- Dr. Jan Van Zundert BV stepped down as director. NBB
- Dimedric BV stepped down as director. NBB
- Dr. Thiessen Steven BV stepped down as director. NBB
In short
From € 34,512 profit in 2022 to € 9,037 loss in 2025.
Paid € 63,666 in corporate taxes since 2022.
Best year ever: 2024, with € 106,234 profit.
A new publication or filing at Anesthesie-Intensieve Geneeskunde-Urgentiegeneeskunde-Pijncentrum ZOL? We notify you, reason included.
Follow Anesthesie-Intensieve Geneeskunde-Urgentiegeneeskunde-Pijncentrum ZOLDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of DR. CREEMERS ANN comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
Anesthesie-Intensieve Geneeskunde-Urgentiegeneeskunde-Pijncentrum ZOLThe shares are held by DR. CREEMERS ANN (100%).
Directors
According to the 2025 annual accounts
Director · represented by Pieter-Jan Van Asbroeck
since 2025 · until 2030
Director · represented by Pieter De Vooght
since 2025 · until 2030
Director · represented by Tom Fivez
since 2025 · until 2030
Director · represented by Ignace Tanghe
since 2025 · until 2030
Director · represented by Jente Grietens
since 2025 · until 2030
Director · represented by Jan Van Zundert
since 2025 · until 2030
Director · represented by Dieter Mesotten
since 2025 · until 2030
Director · represented by Steven Thiessen
since 2025 · until 2030
Shareholders
100%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Weg naar As 141 box 1
3600 Genk
Bessemerstraat 478
3620 Lanaken
Active since 1 March 2018
Schiepse Bos 6
3600 Genk
Active since 1 March 2018
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0691.654.144
- VAT number
- BE 0691.654.144
- Registered office
- Weg naar As 141 bus 1, 3600 Genk
- Names & denominations
- Anesthesie-Intensieve Geneeskunde-Urgentiegeneeskunde-Pijncentrum ZOL · ANIGUP ZOL
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 1 March 2018
- Peppol
- Active · Active since 9 Sept 2025
- Activities · NACE
Activiteiten van medisch specialisten
Overige hospitalisatiediensten